YDYu Ding

Yu Ding

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu Ding has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Tingting Yu

    Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

    4 shared publications
  • Xiumin Wang

    Department of Endocrinology, Genetics and Metabolism, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    4 shared publications
  • Niu Li

    The International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    3 shared publications
  • Guoying Chang

    Department of Endocrinology and Metabolism, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    2 shared publications
  • Shiyang Gao

    Department of Endocrinology and Metabolism, Shanghai Children′s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, shsmu.edu.cn

    2 shared publications
  • Xiaodong Huang

    Wuhan Third Hospital, Wuhan, China

    2 shared publications

Latest Publications

  • Open Access

    Multiomics Mendelian Randomization Identifies Lactylation‐Related Molecular Traits in Type 1 Diabetes

    by Yu Ding, Shiyang Gao, Lingwen Ying, Jie Tang, Guoying Chang, Yiguo Huang, Tingting Yu, Xin Li, Xiumin Wang

    Background: Lactylation is a posttranslational modification involved in cellular metabolic and immune processes. Although dysregulated lactate metabolism has been implicated in type 1 diabetes (T1D), the genetic relevance of lactylation‐related molecular traits remains poorly defined. Methods: Summary‐data–based Mendelian randomization (SMR) was applied to integrate blood‐derived methylation/expression/protein quantitative trait loci (mQTLs/eQTLs/pQTLs) for 353 lactylation‐related genes with a T1D genome‐wide association study (7467 cases and 10,218 controls). The HEIDI test evaluated heterogeneity. Shared genetic signals were assessed by Bayesian colocalization. Associations identified in the discovery analysis were replicated in the FinnGen_R12_T1D and FinnGen_R9_E4_DM1NEU cohorts. mQTL‐eQTL SMR analysis evaluated methylation–expression regulatory relationships. Steiger directionality testing and GTEx tissue eQTL analyses were performed for prioritized genes. Results: SMR prioritized PDAP1 , PNKD , and HMGB1 as candidate genes associated with T1D. At the DNA methylation level, methylation at cg05715492 ( PDAP1 ) was positively associated with T1D risk (OR = 1.29, 95% CI: 1.09–1.53), whereas cg05991184 ( PNKD ) showed an inverse association (OR = 0.73, 95% CI: 0.59–0.90). cg22712983, cg26786924, and cg04880052 in PNKD exhibited positive associations. cg25251738 ( HMGB1 ) methylation was inversely associated with risk (OR = 0.85, 95% CI: 0.75–0.97). At the expression level, genetically predicted PDAP1 (OR = 0.26, 95% CI: 0.10–0.66) and HMGB1 (OR = 0.45, 95% CI: 0.22–0.91) expressions were inversely associated with T1D risk, whereas PNKD expression was positively associated (OR = 1.13, 95% CI: 1.04–1.23). mQTL‐eQTL SMR analyses demonstrated significant methylation–expression associations at PDAP1 , PNKD , and HMGB1 loci. Steiger directionality testing supported the observed associations. In GTEx datasets, higher PNKD expression was associated with increased T1D risk in both whole blood and spleen. Conclusion: PNKD , PDAP1 , and HMGB1 were prioritized as lactylation‐related candidate genes associated with T1D risk through integrated genetic analyses. This finding generates hypothesis for future investigations into the potential involvement of lactylation‐related pathways in T1D pathogenesis.

  • Open Access

    Focusing on Rare Variants Related to Maturity‐Onset Diabetes of the Young in Children

    by Yu Ding, Qianwen Zhang, Shiyang Gao, Juan Li, Guoying Chang, Yirou Wang, Libo Wang, Xin Li, Yao Chen, Ru-En Yao, et al.

    Background: In this study, we analysed the clinical and genetic characteristics and follow‐up data of patients with maturity‐onset diabetes of the young (MODY). Methods: From January 2015 to December 2022, patients with persistent hyperglycaemia suspected of having monogenic diabetes or diabetes syndrome were recruited, and next‐generation sequencing (NGS) was performed at the Shanghai Children’s Medical Center. Patients’ clinical and laboratory findings were recorded preceding follow‐ups. Candidate variants were verified using Sanger sequencing. Variant pathogenicity was evaluated according to the American College of Medical Genetics and Genomics (ACMG) guidelines. Results: Genetic testing was performed in 175 children. MODY‐related pathogenic or likely pathogenic gene variants were identified in 30 patients from different families. Of these, 11 were diagnosed with GCK ‐MODY (36.7%), six with INS ‐MODY (20%), five with HNF1A ‐MODY (16.7%), five with ABCC8 ‐MODY (16.7%), two with HNF1B ‐MODY (6.7%) and one with HNF4A ‐MODY (3.3%). There was one shift variant and seven splice‐site variants, and the rest were missense variants. We discovered six novel variants. Of the 30 patients, 63.3% had a family history of diabetes, 13.3% had diabetic ketoacidosis (DKA), and 16.7% had positive diabetes‐associated autoantibodies. The diabetes phenotype of patients with the INS variant was similar to that of patients with type 1 diabetes. All patients, including those having positive autoantibodies, required long‐term insulin therapy during follow‐ups. Four patients with the ABCC8 variant were unable to switch to oral sulfonylurea therapy and continued insulin therapy. Conclusion: Genetic testing is helpful for the precise diagnosis and treatment of patients with MODY, including those with DKA history and positive diabetes autoantibody. GCK ‐MODY is the most common type of MODY, and patients with INS variant account for a relatively large proportion of MODY cases in our cohort.


  • Open Access

    Identification and functional analysis of novel SOX11 variants in Chinese patients with Coffin-Siris syndrome 9

    by Yu Ding, Jiande Chen, Yijun Tang, Li-Na Chen, Ru-En Yao, Tingting Yu, Yong Yin, Xiumin Wang, Jian Wang, Niu Li

    SOX11 is a transcription factor belonging to the sex determining region Y-related high-mobility group box family that plays a vital role in early embryogenesis and neurogenesis. De novo variants in SOX11 have been initially reported to cause a rare neurodevelopmental disorder, mainly referred to Coffin-siris syndrome 9 (CSS9, OMIM# 615866) which is characterized with growth deficiency, intellectual disability (ID), microcephaly, coarse facies, and hypoplastic nails of the fifth fingers and/or toes. A recent large-scale cohort study suggests that SOX11 variation would result in a clinically and molecularly distinct disease from CSS. Here, we describe three unrelated Chinese cases with variable phenotype, mainly involving developmental delay, ID, short statute, microcephaly, facial deformities (i.e., prominent forehead, arched eye brow, flat nasal bridge, broad nose and short philtrum), and cryptorchidism. Whole-exome sequencing (WES) revealed three novel heterozygous variants in the SOX11 gene, including two missense variants of c.337T>C (p.Y113H) and c.425C>G (p.A142G), and one nonsense variant of c.820A>T (p. K142*). Luciferase reporting assay shows that the two missense variants impair the transcriptional activity of the SOX11 target gene GDF5. Additionally, WES uncovered a 4,300 kb deletion involving the region of 1q24.2-q25.1 (hg19,chr1:169,433,149-173,827,682) in patient 1, which also contributes to the condition of the patient. In summary, this is the first report of Chinese cases with de novo variants of SOX11. Our study partially supports the previous observation that the phenotype caused by SOX11 variants somewhat differs from classical CSS.


  • Open Access

    Clinical and genetic analysis in a Chinese cohort of children and adolescents with diabetes/persistent hyperglycemia

    by Yu Ding, Niu Li, Dan Lou, Qianwen Zhang, Guoying Chang, Juan Li, Xin Li, Qun Li, Xiaodong Huang, Jian Wang, et al.

    Aims/Introduction To investigate the genetic etiology and evaluate the diagnostic application of next‐generation sequencing for diabetes/persistent hyperglycemia in children and adolescents. Materials and Methods Patients with diabetes/persistent hyperglycemia, presenting with at least one other clinical manifestation (other than diabetes) or with a family history of diabetes, were recruited. The clinical and laboratory characteristics of the patients were recorded. Next‐generation sequencing was carried out, and candidate variants were verified by Sanger sequencing. Variant pathogenicity was further evaluated according to the American College of Medical Genetics and Genomics guidelines. Results This study included 101 potential probands, 36 of whom were identified as positive by genetic testing. A further 51.2 and 20.9% of variants were determined to be pathogenic or likely pathogenic, respectively. Variants associated with the disease were primarily identified in 21 genes and three regions of copy number variants. Among the 39 variants in 21 genes, 61.5% (24/39) were novel. The genetic diagnosis of 23 patients was confirmed based on genetic evidence and associated clinical manifestations. We reported GCK variants (21.7%, 5/23) as the most common etiology in our cohort. Different clinical manifestations were observed in one family with WFS1 variants. Conclusions Our findings support the use of next‐generation sequencing as a standard method in patients with diabetes/persistent hyperglycemia and provide insights into the etiologies of these conditions.


  • Open Access

    Evaluation of basal sex hormone levels for activation of the hypothalamic–pituitary–gonadal axis

    by Yu Ding, Juan Li, Yongguo Yu, Peirong Yang, Huaiyuan Li, Yongnian Shen, Xiaodong Huang, Shijian Liu

    Background: This study aimed to identify the predictive value of basal sex hormone levels for activation of the hypothalamic–pituitary–gonadal (HPG) axis in girls.Methods: Gonadotropin-releasing hormone (GnRH) stimulation tests were performed and evaluated in a total of 1750 girls with development of secondary sex characteristics. Correlation analyses were conducted between basal sex hormones and peak luteinizing hormone (LH) levels ≥5 IU/L during the GnRH stimulation test. Receiver operating characteristic (ROC) curves for basal levels of LH, follicle-stimulating hormone (FSH), LH/FSH, and estradiol (E2) before the GnRH stimulation test were plotted. The area under the curve (AUC) and 95% confidence intervals (CIs) were measured for each curve.Results: The maximum AUC value was observed for basal LH levels (0.77, 95% CI: 0.74–0.79), followed by basal FSH levels (0.73, 95% CI: 0.70–0.75), the basal LH/FSH ratio (0.68, 95% CI: 0.65–0.71), and basal E2 levels (0.61, 95% CI: 0.59–0.64). The appropriate cutoff value of basal LH levels associated with a positive response of the GnRH stimulation test was 0.35 IU/L, with a sensitivity of 63.96% and specificity of 76.3% from the ROC curves when Youden’s index showed the maximum value. When 100% of patients had peak LH levels ≥5 IU/L, basal LH values were >2.72 IU/L, but the specificity was only 5.45%.Conclusions: Increased basal LH levels are a significant predictor of a positive response during the GnRH stimulation test for assessing activation of the HPG axis in most girls with early pubertal signs.


  • Open Access

    Novel mutations in the CYP11B2 gene causing aldosterone synthase deficiency

    by Niu Li, Juan Li, Yu Ding, Tingting Yu, Yongnian Shen, Qihua Fu, Yiping Shen, Xiaodong Huang, Jian Wang

    Aldosterone synthase deficiency (ASD) is a rare, autosomal recessive inherited disease. Mutations in the CYP11B2 gene are responsible for the occurrence of ASD, and the clinical manifestations of ASD vary with age. Affected infants may develop symptoms of mineralocorticoid deficiency, including clinical presentation with frequent vomiting, a variable degree of hyponatremia, hyperkalemia, and metabolic acidosis combined with poor growth, which are easily confused with several other endocrine genopathies, including pseudohypoaldosteronism type 1 and congenital adrenal hyperplasia. In the present study, whole exome sequencing (WES) was used to screen for causal variants in the genome of a Chinese pediatric patient with confusing endocrine disorder symptoms. Clinical symptoms of frequent vomiting, hyponatremia and hyperkalemia were selected as the filtering indices to analyze the WES data. Clinically relevant variants were subsequently verified using Sanger sequencing. Minigene construct analysis was used to assess the consequence of a splicing variant in the CYP11B2 gene. The compound heterozygous mutations, c.1009C>T and c.240‑1G>A, in the CYP11B2 gene were identified and confirmed, and represented novel variants. Sequence analysis results revealed that the c.1009C>T mutation at codon 337 of exon 6 was a nonsense mutation, which led to early termination of the protein translation process. In addition, further investigation of the splicing pattern in a minigene construct showed that the c.240‑1G>A mutation led to the preservation of intron 1, with the 3'‑splice site disappearing during transcriptional processing of the mRNA. Using molecular genetic assessments, the patient was finally diagnosed with ASD. Therefore, the present study identified two novel CYP11B2 gene mutations in a Chinese patient with ASD, indicating exome sequencing as an effective diagnostic tool for rare endocrine-metabolic diseases.